Novartis is on the final straight to approval of its spinal muscular atrophy (SMA) gene therapy Zolgensma in the EU, after getting a recommendation for approval from the CHMP. The positive opinion ...

Novartis is set to launch its one-off gene therapy Zolgensma for the ultra-rare muscle-wasting disease spinal muscular atrophy (SMA) in Germany at the start of July priced at 1,945,000 euros, and says ...

The couple stepped out to support Blunt's new film 'The Smashing Machine' Hedy Phillips is the Senior Style News Editor at PEOPLE. She has been working at PEOPLE since 2022. Her work has previously ...

J.B. Maverick is an active trader, commodity futures broker, and stock market analyst 17+ years of experience, in addition to 10+ years of experience as a finance writer and book editor. Somer G.

Kathy Lien is a founding partner and the managing director of FX strategy at BK Asset Management, directing the firm's analytical techniques. Thomas J Catalano is a CFP and Registered Investment ...

SMA and Create Energy announced they will work together to manufacture both the Sunny Highpower PEAK3 and the fully-integrated PowerSkid solution in the United States. The two companies signed an MOU ...

The software update includes additional file checks and helps users remove the known rootkit deployed in a recent campaign. SonicWall has released a fresh software update for its SMA 100 appliances to ...

More than 30,000 people have crossed the English Channel since the start of year. The latest Home Office statistics show that almost two-fifths of those who claimed asylum in the UK in the 12 months ...

Chart does not reflect overnight price.

For the freshest news, join The Borneo Post's Telegram Channel and The Borneo Post on Newswav.

Abstract: Energy trading in industrial parks has great potential for reducing carbon emissions and lowering energy bills. This article proposes a safe multiagent deep reinforcement learning algorithm ...

The central government announced a complete GST exemption on 36 lifesaving medicines on Monday September 22, covering cancer therapies, treatments for rare genetic disorders, and drugs for chronic ...